Tasly took part in a $30.2m round for medical imaging services provider Keya Medical Technology, which has now raised cash three times this year.

Nestlé and Cedars-Sinai Medical Center participated in a round that came four months after the precision IBD therapy developer rebranded from Precision IBD.

Corporate venturing units GV and SR One both reinvested as the hearing loss therapy developer pushed its overall funding past the $190m mark.

Crown Bioscience spinoff Apollomics has closed a round led by Ping An Capital that will support clinical testing of its immuno-oncology drug pipeline.

Tencent and Legal & General co-led a series C round for genomic testing software provider Congenica that will fund the expansion of its partnership activities.

Diagnostics technology provider Sofie has completed a $27.4m series C round led by $25m from Jubilant Radiopharma at a $100m valuation.

Mental health support service Koa Health has spun off and reached the $16.5m first close for a series A round co-led by Ancora Finance Group and Wellington Partners.

Tampa General Hospital will begin a diversified corporate venturing programme when Rachel Feinman joins it in early 2021.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Takeda Ventures and Chiesi Ventures are set to exit the cancer drug developer through the deal, which came after just over $200m in funding.